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Abstract
Background: Effective prevention and control strategies are mandatory to prevent SARS-CoV-2 infection.
Main text: The Italian Pediatric Respiratory Society promotes a series of new recommendations that should be
followed in pulmonary function testing laboratories during the COVID-19 pandemic.
Conclusion: Pulmonary function testing should be performed in children with chronic lung disease only if it is
needed to guide management and limited to the necessary tests, namely spirometry. When performed, strict
infection control measures should be followed due to the potential risk of transmitting SARS-CoV-2.
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Main text
The coronavirus disease 2019 (COVID-19) is a public
health emergency of international concern caused by a
newly discovered coronavirus (severe acute respiratory
syndrome coronavirus 2, SARS-CoV-2) [1]. Person-to-
person transmission of SARS-CoV-2 occurs primarily
through close contact with an infected person, mainly
occurring via respiratory droplets and after touching
contaminated objects [1]. Accordingly, pulmonary func-
tion testing (PFT) could be considered at high-risk for
viral transmission due to the potential for coughing and
droplet formation during PFT procedures [2]. The most
likely surfaces for possible contamination by this route
are mouthpieces, proximal valves, and tubing. Also, both
technical and clinical staff are usually in close contact
with the patient during PFT for achieving optimal co-
operation and best results [2].
Effective prevention and control strategies are
mandatory to prevent SARS-CoV-2 infection in the PFT
laboratories.
The Italian Pediatric Respiratory Society (IPRS) pro-
motes a series of new recommendations that should be
followed by healthcare workers in PFT laboratories dur-
ing the COVID-19 pandemic.
1. Routine PFT should not be performed to reduce
the risk of viral transmission. When necessary, PFT
should be limited to the essential tests, namely
spirometry. Spirometry should be considered
essential only if therapeutic decisions are urgent in
children with chronic lung disease (cystic fibrosis,
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primary ciliary dyskinesia, severe uncontrolled
asthma, lung transplantation, onco-haematological
diseases before and after hematopoietic stem cell
transplantation), following adequate infection con-
trol measures. Outside these indications, PFT
should only be performed if required by the
pediatric pulmonologist since some individual cir-
cumstances may be unique or require contextual
consideration. Decisions of performing PFT should
be balanced between the potential risks and the
need for PFT to make any therapeutic decision [2].
2. It is strongly recommended not to perform PFT
in confirmed or suspected cases of COVID-19.
PFT should be postponed after the resolution of
symptoms and two negative real-time Polymerase
Chain Reaction (RT-PCR) tests on nasopharynx
and throat swabs for SARS-CoV-2 performed at
24-h interval [3].
3. Appropriate procedures and measures during the
COVID-19 pandemic should be put in place in
order to target 1) clinical and technical staff of PFT
laboratory; 2) children and their caregivers; 3) PFT
machines and devices; 4) environmental cleaning
and disinfection.
4. The clinical and technical staff in the PFT
laboratory are required to adhere to the World
Health Organization (WHO) technical document
that highlights the rights and responsibilities of
healthcare professionals [4]. A specific regulatory
protocol has been signed on March 14th, 2020 by
unions and companies in agreement with the Italian
government to protect the health and safety of
workers from possible infection with SARS-CoV-2
and ensure the safety of the work environment [5].
This regulatory protocol should be adopted within
all workplaces, including hospital facilities, in
addition to the provisions of the Italian Prime Min-
ister’s Decree of March 11th, 2020 [6].
5. Beyond community prevention measures that
comply with the WHO guidelines [7], additional
measures are necessary for healthcare professionals
who perform PFT in order to preserve themselves
and prevent the spreading of the virus in the health
community. At this purpose, it is recommended to
follow the indications delivered by the Italian
“Istituto Superiore di Sanità” (ISS) Working Group
on Infection Prevention and Control [8] concerning
put on, use, take off and dispose of personal
protective equipment, such as masks, disposable
gowns, gloves, goggles or face shields, in the specific
work context and job carried out.
6. All healthcare professionals should be adequately
trained and updated on the risks of occupational
exposure and the available prevention and
protection measures. They should follow established
occupational safety and health procedures, and
avoid exposing themselves and others to health and
safety risks. Recommendations on maintaining
hygiene in a PFT laboratory are particularly relevant
for protecting patients and healthcare professionals
and for providing a safe and work environment [4].
7. Patients’ access (including any single accompanying
person) to the areas dedicated to performing PFT
should be allowed after having checked the absence
of fever (body temperature < 37.5 °C) and any sign/
symptom of respiratory disease (e.g., cough,
shortness of breath). Patients and any single
accompanying person will be asked to sanitize their
hands with a hydro-alcoholic solution (or with soap
and water) for at least 30 s and wear a surgical
mask. Immunocompromised patients should be
scheduled for testing at the start of the day, before
other patients arrive, whereas infected patients
should be scheduled for testing at the end of the
day to prevent cross-infection. Patients/subjects
should be isolated in a separate area for testing to
minimize contacts with potentially infectious pa-
tients. It is very important that patients who present
with acute respiratory symptoms wear a surgical
mask. When applicable, a distance of at least one
meter from the patient should be maintained. Mea-
sures for COVID-19 prevention and control should
be engaged in addition to standard measures for
preventing and controlling cross-infection acquired
from the PFT laboratory.
8. Implementing hygiene control rules (handwashing,
use of gloves for handling the mouthpieces or
internal surfaces of the spirometer) prevents the
spread of infections from the patient to healthy
subjects and healthcare professionals. Sources of
cross-infection in a PFT laboratory include direct
contact, aerosolized particles, saliva, and skin con-
tact. Mouthpieces have the highest risk of contam-
ination since they come in direct contact with the
patient. Mouthpieces need to be replaced after
every use to minimize the risk of cross-infection.
Overall, to perform PFT, disposable materials (fil-
ters, mouthpieces, nose clips, flow sensors) should
be discarded after a single use. Where reusable
items are utilized, they should be managed carefully
and should be thoroughly cleaned and disinfected
as recommended by manufacturers and local infec-
tion control policy.
9. We recommend enhanced cleaning and disinfection
procedures for both the PFT laboratory and
equipment. The testing space and equipment
should be cleaned with chlorine solutions at a
concentration of 1000 ppM or with polyphenol
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solution at a concentration of 1%, according to the
manufacturer’s indications. Biological waste should
be handled appropriately and disposed to reduce
the risk of cross-infection. Separation of infectious
and noninfectious waste help to control infection.
Solid infectious waste should be discarded in con-
tainers labelled with the universal symbol of bio-
logical hazards. Routine cleaning of floors with
detergent and water is recommended as dust and
dirt may neutralize the action of disinfectant or
sterilant. Therefore, disinfection should always be
undertaken with a detergent cleaner [9].
10. Pressurized metered-dose inhaler (pMDI) via a spa-
cer should be considered the preferred device for
the administration of any drugs (e.g., salbutamol).
The use of nebulizers should be avoided to decrease
the risk of disseminating COVID-19 to other pa-
tients and to physicians, nurses and other personnel
in the laboratory, unless an airborne infection isola-
tion room is available [10]. Spacers should not be
shared among patients.
Conclusions
COVID-19 is an emerging, rapidly evolving situation,
and the IPRS is following developments closely.
During the COVID-19 containment phase, the IPRS
recommends avoiding routine PFT and limiting to the
necessary tests, namely spirometry. PFT should be per-
formed in children with chronic lung disease only if it is
needed to guide management and if comprehensive in-
fection control can be maintained in the PFT laborator-
ies. When performing PFT, strict infection control
measures should be followed.
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